Clinical study on lung cancer as a second primary cancer. 1998

T Utsumi, and Y Fujii, and S Takeda, and M Minami, and H E Yoon, and M Okumura, and H Matsuda
First Department of Surgery, Osaka University Medical School, Suita, Japan.

This study evaluates the effect of a previous cancer on the clinical characteristics and the outcome of lung cancer patients. The 313 primary lung cancer patients operated on in the Osaka University Hospital during the period 1984-1993 were reviewed. Of those, 37 had a history of previous cancer. In the lung cancer patients with a history of previous cancer, 20 had adenocarcinomas, 14 had squamous cell carcinomas, while 3 had other cancers. The previous malignancies included 13 gastric cancers, 10 head and neck cancers, 6 colorectal cancers, and 8 others. The pathological stage was 17 stage I, 1 stage II, 15 stage IIIA, 1 stage IIIB, and 3 stage IV. The 5-year survival rate was 37.9%. In patients without a history of previous cancer, there were 139 adenocarcinomas, 100 squamous cell carcinomas, and 37 others. The pathological stage was 126 stage I, 33 stage II, 74 stage IIIA, 23 stage IIIB, and 20 stage IV. The 5-year survival rate was 43.3%. There were no significant differences in the cell type, stage, or survival between the lung cancers found as the first and second cancers. Lung cancer patients with a history of previous cancer are expected to respond to a resection as well as those with lung cancer appearing as their first cancer.

UI MeSH Term Description Entries
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002294 Carcinoma, Squamous Cell A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed) Carcinoma, Epidermoid,Carcinoma, Planocellular,Carcinoma, Squamous,Squamous Cell Carcinoma,Carcinomas, Epidermoid,Carcinomas, Planocellular,Carcinomas, Squamous,Carcinomas, Squamous Cell,Epidermoid Carcinoma,Epidermoid Carcinomas,Planocellular Carcinoma,Planocellular Carcinomas,Squamous Carcinoma,Squamous Carcinomas,Squamous Cell Carcinomas
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000230 Adenocarcinoma A malignant epithelial tumor with a glandular organization. Adenocarcinoma, Basal Cell,Adenocarcinoma, Granular Cell,Adenocarcinoma, Oxyphilic,Adenocarcinoma, Tubular,Adenoma, Malignant,Carcinoma, Cribriform,Carcinoma, Granular Cell,Carcinoma, Tubular,Adenocarcinomas,Adenocarcinomas, Basal Cell,Adenocarcinomas, Granular Cell,Adenocarcinomas, Oxyphilic,Adenocarcinomas, Tubular,Adenomas, Malignant,Basal Cell Adenocarcinoma,Basal Cell Adenocarcinomas,Carcinomas, Cribriform,Carcinomas, Granular Cell,Carcinomas, Tubular,Cribriform Carcinoma,Cribriform Carcinomas,Granular Cell Adenocarcinoma,Granular Cell Adenocarcinomas,Granular Cell Carcinoma,Granular Cell Carcinomas,Malignant Adenoma,Malignant Adenomas,Oxyphilic Adenocarcinoma,Oxyphilic Adenocarcinomas,Tubular Adenocarcinoma,Tubular Adenocarcinomas,Tubular Carcinoma,Tubular Carcinomas
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective

Related Publications

T Utsumi, and Y Fujii, and S Takeda, and M Minami, and H E Yoon, and M Okumura, and H Matsuda
December 1978, Cancer,
T Utsumi, and Y Fujii, and S Takeda, and M Minami, and H E Yoon, and M Okumura, and H Matsuda
January 2020, Frontiers in oncology,
T Utsumi, and Y Fujii, and S Takeda, and M Minami, and H E Yoon, and M Okumura, and H Matsuda
August 1990, Anales de medicina interna (Madrid, Spain : 1984),
T Utsumi, and Y Fujii, and S Takeda, and M Minami, and H E Yoon, and M Okumura, and H Matsuda
January 1995, International surgery,
T Utsumi, and Y Fujii, and S Takeda, and M Minami, and H E Yoon, and M Okumura, and H Matsuda
June 2019, Cancer medicine,
T Utsumi, and Y Fujii, and S Takeda, and M Minami, and H E Yoon, and M Okumura, and H Matsuda
April 1995, The Annals of thoracic surgery,
T Utsumi, and Y Fujii, and S Takeda, and M Minami, and H E Yoon, and M Okumura, and H Matsuda
December 1983, IMJ. Illinois medical journal,
T Utsumi, and Y Fujii, and S Takeda, and M Minami, and H E Yoon, and M Okumura, and H Matsuda
January 2020, PloS one,
T Utsumi, and Y Fujii, and S Takeda, and M Minami, and H E Yoon, and M Okumura, and H Matsuda
April 2009, Annals of surgical oncology,
T Utsumi, and Y Fujii, and S Takeda, and M Minami, and H E Yoon, and M Okumura, and H Matsuda
June 1987, Nihon Kyobu Shikkan Gakkai zasshi,
Copied contents to your clipboard!